These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 15665300)

  • 21. A mouse embryonic stem cell model of Schwann cell differentiation for studies of the role of neurofibromatosis type 1 in Schwann cell development and tumor formation.
    Roth TM; Ramamurthy P; Ebisu F; Lisak RP; Bealmear BM; Barald KF
    Glia; 2007 Aug; 55(11):1123-33. PubMed ID: 17597122
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neurofibromatosis Type 1 and tumorigenesis: molecular mechanisms and therapeutic implications.
    Gottfried ON; Viskochil DH; Couldwell WT
    Neurosurg Focus; 2010 Jan; 28(1):E8. PubMed ID: 20043723
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stimulus-evoked release of neuropeptides is enhanced in sensory neurons from mice with a heterozygous mutation of the Nf1 gene.
    Hingtgen CM; Roy SL; Clapp DW
    Neuroscience; 2006; 137(2):637-45. PubMed ID: 16298082
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NF1 modulates the effects of Ras oncogenes: evidence of other NF1 function besides its GAP activity.
    Corral T; Jiménez M; Hernández-Muñoz I; Pérez de Castro I; Pellicer A
    J Cell Physiol; 2003 Nov; 197(2):214-24. PubMed ID: 14502561
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular targets for emerging anti-tumor therapies for neurofibromatosis type 1.
    Dilworth JT; Kraniak JM; Wojtkowiak JW; Gibbs RA; Borch RF; Tainsky MA; Reiners JJ; Mattingly RR
    Biochem Pharmacol; 2006 Nov; 72(11):1485-92. PubMed ID: 16797490
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phosphorylation of neurofibromin by PKC is a possible molecular switch in EGF receptor signaling in neural cells.
    Mangoura D; Sun Y; Li C; Singh D; Gutmann DH; Flores A; Ahmed M; Vallianatos G
    Oncogene; 2006 Feb; 25(5):735-45. PubMed ID: 16314845
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neurofibromin: a general outlook.
    Trovó-Marqui AB; Tajara EH
    Clin Genet; 2006 Jul; 70(1):1-13. PubMed ID: 16813595
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neurofibromin regulates G protein-stimulated adenylyl cyclase activity.
    Tong J; Hannan F; Zhu Y; Bernards A; Zhong Y
    Nat Neurosci; 2002 Feb; 5(2):95-6. PubMed ID: 11788835
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NF1 tumor suppressor protein and mRNA in skeletal tissues of developing and adult normal mouse and NF1-deficient embryos.
    Kuorilehto T; Nissinen M; Koivunen J; Benson MD; Peltonen J
    J Bone Miner Res; 2004 Jun; 19(6):983-9. PubMed ID: 15125795
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A mouse model for the learning and memory deficits associated with neurofibromatosis type I.
    Silva AJ; Frankland PW; Marowitz Z; Friedman E; Laszlo GS; Cioffi D; Jacks T; Bourtchuladze R
    Nat Genet; 1997 Mar; 15(3):281-4. PubMed ID: 9054942
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The cell of origin dictates the temporal course of neurofibromatosis-1 (Nf1) low-grade glioma formation.
    Solga AC; Toonen JA; Pan Y; Cimino PJ; Ma Y; Castillon GA; Gianino SM; Ellisman MH; Lee DY; Gutmann DH
    Oncotarget; 2017 Jul; 8(29):47206-47215. PubMed ID: 28525381
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heterozygosity for the neurofibromatosis 1 (NF1) tumor suppressor results in abnormalities in cell attachment, spreading and motility in astrocytes.
    Gutmann DH; Wu YL; Hedrick NM; Zhu Y; Guha A; Parada LF
    Hum Mol Genet; 2001 Dec; 10(26):3009-16. PubMed ID: 11751683
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neurofibromatosis 1: closing the GAP between mice and men.
    Dasgupta B; Gutmann DH
    Curr Opin Genet Dev; 2003 Feb; 13(1):20-7. PubMed ID: 12573431
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neurofibroma-associated growth factors activate a distinct signaling network to alter the function of neurofibromin-deficient endothelial cells.
    Munchhof AM; Li F; White HA; Mead LE; Krier TR; Fenoglio A; Li X; Yuan J; Yang FC; Ingram DA
    Hum Mol Genet; 2006 Jun; 15(11):1858-69. PubMed ID: 16648142
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of the potential pathogenicity of missense mutations identified in the GTPase-activating protein (GAP)-related domain of the neurofibromatosis type-1 (NF1) gene.
    Thomas L; Richards M; Mort M; Dunlop E; Cooper DN; Upadhyaya M
    Hum Mutat; 2012 Dec; 33(12):1687-96. PubMed ID: 22807134
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumorigenic properties of neurofibromin-deficient Schwann cells in culture and as syngrafts in Nf1 knockout mice.
    Wu M; Wallace MR; Muir D
    J Neurosci Res; 2005 Nov; 82(3):357-67. PubMed ID: 16180234
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genome-wide single-nucleotide polymorphism analysis in juvenile myelomonocytic leukemia identifies uniparental disomy surrounding the NF1 locus in cases associated with neurofibromatosis but not in cases with mutant RAS or PTPN11.
    Flotho C; Steinemann D; Mullighan CG; Neale G; Mayer K; Kratz CP; Schlegelberger B; Downing JR; Niemeyer CM
    Oncogene; 2007 Aug; 26(39):5816-21. PubMed ID: 17353900
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular genetic analyses in neurofibromatosis type 1 patients with tumors.
    Oguzkan S; Terzi YK; Cinbis M; Anlar B; Aysun S; Ayter S
    Cancer Genet Cytogenet; 2006 Mar; 165(2):167-71. PubMed ID: 16527612
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation of the tyrosinase gene promoter by neurofibromin.
    Suzuki H; Takahashi K; Yasumoto K; Shibahara S
    Biochem Biophys Res Commun; 1994 Dec; 205(3):1984-91. PubMed ID: 7811291
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neurofibromatosis 1 (NF1) heterozygosity results in a cell-autonomous growth advantage for astrocytes.
    Bajenaru ML; Donahoe J; Corral T; Reilly KM; Brophy S; Pellicer A; Gutmann DH
    Glia; 2001 Mar; 33(4):314-23. PubMed ID: 11246230
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.